New drug trial targets weight and heart health together
NCT ID NCT06820099
Summary
This study is testing whether an investigational drug called HRS-7535 can help adults who have both heart failure and obesity. About 225 participants will receive either the drug or a placebo for 36 weeks to see if it helps with weight control and heart failure symptoms. The main goal is to measure changes in body weight, while also checking safety and effects on inflammation.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADULTS WITH HEART FAILURE, MILD DECREASE IN EJECTION FRACTION/PRESERVED EJECTION FRACTION, AND OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fuwai Hospital, Chinese Academy of Medical Sciences
RECRUITINGBeijing, Beijing Municipality, 100032, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.